Cosibelimab OK'd for Cutaneous Squamous Cell Carcinoma

(MedPage Today) -- The FDA approved cosibelimab (Unloxcyt) for treating metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) in adults who are not candidates for curative surgery or radiation.
Approval of the new PD-L1 blocking...